# The FDA has blocked the publication of studies regarding the safety of COVID-19 and shingles vaccines.

*business · news · 2026-05-06 · Devdiscourse*

## Key points

- The FDA has blocked the publication of studies on COVID-19 and shingles vaccine safety.
- The FDA approved fruit-flavored e-cigarettes by Glas Inc., the first non-tobacco flavor authorization.
- Novo Nordisk outperformed profit forecasts due to strong demand for its new weight-loss pill.
- Gilead Sciences' HIV injection Yeztugo faces obstacles from insurance gaps and cost-sharing issues.

**Companies:** Novo Nordisk, CVS Health, Gilead Sciences, Bayer
**Countries:** United States, Germany

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3898811-controversial-fda-decisions-and-emerging-health-trends)

---

Canonical: https://newsio.io/n/91aad6b7-2112-4b0e-8677-d364556b1efd/the-fda-has-blocked-the-publication-of-studies-regarding-the-safety-of-covid-19
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works